The Discounted Cash Flow (DCF) valuation of Regenxbio Inc (RGNX) is (145.41) USD. With the latest stock price at 9.06 USD, the upside of Regenxbio Inc based on DCF is -1704.9%.
Based on the latest price of 9.06 USD and our DCF valuation, Regenxbio Inc (RGNX) is a sell. selling RGNX stocks now will result in a potential gain of 1704.9%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.0% - 8.4% | 7.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (456.55) - (88.42) | (145.41) |
| Upside | -5139.2% - -1075.9% | -1704.9% |